Update: 20.12.2022
Last week: 49 week 2022 (05.12.2022 - 11.12.2022)
Last full month: November 2022
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE BERLIN-CHEMIE | |||||||||
| WoW | 225 046 | 22.8% | 3.4% | 0.1 | 52 067 284 | 22.7% | 3.5% | 0.1 | 19.0% |
| MoM | 604 970 | -8.8% | 3.3% | -0.5 | 138 517 736 | -2.4% | 3.4% | -0.4 | 4.9% |
| YTD | 9 272 342 | -25.4% | 5.0% | -1.5 | 1 878 963 974 | -12.0% | 4.8% | -1 | -3.4% |
| MAT | 10 111 960 | -20.9% | 5.0% | -1 | 2 035 267 402 | -7.5% | 4.9% | -0.6 | -4.9% |
| DEXALGIN | |||||||||
| WoW | 18 160 | 7.9% | 0.3% | 0 | 8 556 840 | 1.2% | 1.0% | -0.1 | 13.6% |
| MoM | 67 963 | -21.8% | 0.3% | -0.1 | 33 907 140 | -21.4% | 1.1% | -0.3 | -3.7% |
| YTD | 1 523 453 | -11.3% | 0.6% | -0.1 | 656 282 783 | 0.5% | 1.7% | -0.2 | -0.8% |
| MAT | 1 645 633 | -11.0% | 0.6% | -0.1 | 704 091 180 | 0.2% | 1.8% | -0.1 | -2.6% |
| ESPUMISAN (ADULTS) | |||||||||
| WoW | 56 822 | 1.0% | 41.7% | 0.7 | 32 410 765 | 3.9% | 48.2% | 0.6 | -0.7% |
| MoM | 240 711 | 0.5% | 41.3% | -1.5 | 131 026 847 | 4.0% | 48.3% | -0.8 | 4.1% |
| YTD | 4 124 267 | -17.2% | 53.7% | -12.6 | 2 113 177 077 | -7.3% | 59.3% | -11.3 | 2.2% |
| MAT | 4 427 873 | -17.0% | 54.1% | -11.9 | 2 258 705 513 | -7.1% | 59.8% | -10.6 | 1.2% |
| ESPUMISAN BABY | |||||||||
| WoW | 23 738 | -9.5% | 31.6% | -1.7 | 16 611 784 | -8.1% | 46.9% | -1 | -4.6% |
| MoM | 103 328 | 2.6% | 33.8% | 1.4 | 69 479 607 | 5.8% | 47.4% | 1.6 | -1.6% |
| YTD | 1 360 829 | -13.6% | 37.3% | -4.2 | 858 458 653 | -6.7% | 50.6% | -5.7 | -3.9% |
| MAT | 1 448 518 | -15.5% | 37.4% | -4.2 | 910 160 434 | -8.7% | 50.7% | -5.5 | -6.1% |
| FASTUM | |||||||||
| WoW | 14 962 | -5.7% | 0.8% | 0 | 8 384 565 | -8.3% | 2.1% | -0.1 | -1.2% |
| MoM | 72 086 | 12.1% | 0.9% | 0.1 | 40 966 576 | 12.7% | 2.4% | 0.3 | -1.3% |
| YTD | 995 202 | -24.4% | 1.1% | -0.4 | 520 452 949 | -14.2% | 2.5% | -0.6 | -0.1% |
| MAT | 1 064 212 | -25.5% | 1.1% | -0.4 | 553 700 063 | -15.7% | 2.5% | -0.6 | -1.9% |
| IODOMARIN | |||||||||
| WoW | 70 586 | 0.8% | 22.5% | 0.1 | 12 994 835 | 0.7% | 9.1% | 0 | 0.2% |
| MoM | 299 606 | -16.4% | 23.2% | -1 | 55 472 593 | -16.2% | 9.8% | -0.8 | -12.7% |
| YTD | 3 103 435 | 4.8% | 20.5% | 0 | 605 148 471 | 9.1% | 9.1% | -0.2 | 4.6% |
| MAT | 3 309 145 | 6.5% | 20.6% | 0.7 | 642 790 721 | 10.1% | 9.2% | 0.1 | 3.0% |
| LIOTON | |||||||||
| WoW | 13 943 | -19.5% | 1.4% | -0.4 | 15 838 166 | -21.6% | 3.6% | -0.8 | 1.2% |
| MoM | 72 321 | 5.9% | 1.8% | 0.2 | 83 457 879 | 9.9% | 4.3% | 0.5 | -4.0% |
| YTD | 1 206 059 | -25.5% | 2.2% | -0.5 | 1 252 519 965 | -6.5% | 4.6% | -1 | -7.5% |
| MAT | 1 278 474 | -25.8% | 2.3% | -0.5 | 1 316 347 346 | -7.2% | 4.7% | -0.9 | -8.8% |
| MEZYM | |||||||||
| WoW | 219 530 | 1.5% | 17.7% | -0.3 | 32 581 420 | 2.4% | 12.5% | 0.3 | 2.9% |
| MoM | 921 273 | 0.0% | 18.4% | -0.3 | 136 606 124 | -2.7% | 12.9% | -0.6 | 1.9% |
| YTD | 16 600 205 | -14.5% | 25.8% | -3.2 | 2 532 793 758 | -6.6% | 18.4% | -3.2 | -3.8% |
| MAT | 17 939 607 | -14.5% | 26.1% | -2.9 | 2 729 290 008 | -6.8% | 18.7% | -3 | -5.2% |
| MIG 400 | |||||||||
| WoW | 144 574 | 7.9% | 2.4% | -0.1 | 17 419 076 | 8.0% | 2.0% | 0 | 13.6% |
| MoM | 558 202 | -5.5% | 2.8% | -0.1 | 67 227 770 | -5.7% | 2.2% | -0.1 | -3.7% |
| YTD | 7 956 944 | -15.2% | 3.2% | -0.6 | 939 668 251 | -11.2% | 2.5% | -0.6 | -0.8% |
| MAT | 8 466 060 | -15.8% | 3.3% | -0.5 | 998 243 738 | -11.9% | 2.5% | -0.6 | -2.6% |
| PROSTAMOL | |||||||||
| WoW | 23 855 | -3.7% | 13.3% | -0.3 | 32 702 984 | -4.5% | 14.0% | -0.2 | -1.5% |
| MoM | 101 766 | -2.9% | 14.1% | -1.3 | 140 977 526 | -2.3% | 14.9% | -1.4 | 6.2% |
| YTD | 1 478 700 | -27.2% | 18.4% | -6.3 | 2 068 941 047 | -19.0% | 19.6% | -7.3 | -2.1% |
| MAT | 1 588 472 | -27.2% | 18.6% | -5.9 | 2 213 255 136 | -19.2% | 19.9% | -6.8 | -4.1% |
| RESPERO MYRTOL | |||||||||
| WoW | 37 106 | 18.2% | 7.8% | 0.3 | 18 788 729 | 17.8% | 8.4% | 0.3 | 13.4% |
| MoM | 102 019 | 2.1% | 7.0% | -0.6 | 51 471 720 | 5.2% | 7.5% | -0.4 | 11.1% |
| YTD | 1 187 714 | 80.2% | 8.3% | 3.5 | 563 510 951 | 83.8% | 8.4% | 3.3 | 4.6% |
| MAT | 1 275 325 | 83.8% | 8.3% | 3.7 | 601 783 755 | 86.3% | 8.4% | 3.4 | 3.2% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 9 272 342 | -25.4% | 5.0% | -1.5 | 1 878 963 974 | -12.0% | 4.8% | -1 | -3.4% |
| DEXALGIN | 1 523 453 | -11.3% | 0.6% | -0.1 | 656 282 783 | 0.5% | 1.7% | -0.2 | -0.8% |
| ESPUMISAN (ADULTS) | 4 124 267 | -17.2% | 53.7% | -12.6 | 2 113 177 077 | -7.3% | 59.3% | -11.3 | 2.2% |
| ESPUMISAN BABY | 1 360 829 | -13.6% | 37.3% | -4.2 | 858 458 653 | -6.7% | 50.6% | -5.7 | -3.9% |
| FASTUM | 995 202 | -24.4% | 1.1% | -0.4 | 520 452 949 | -14.2% | 2.5% | -0.6 | -0.1% |
| IODOMARIN | 3 103 435 | 4.8% | 20.5% | 0 | 605 148 471 | 9.1% | 9.1% | -0.2 | 4.6% |
| LIOTON | 1 206 059 | -25.5% | 2.2% | -0.5 | 1 252 519 965 | -6.5% | 4.6% | -1 | -7.5% |
| MEZYM | 16 600 205 | -14.5% | 25.8% | -3.2 | 2 532 793 758 | -6.6% | 18.4% | -3.2 | -3.8% |
| MIG 400 | 7 956 944 | -15.2% | 3.2% | -0.6 | 939 668 251 | -11.2% | 2.5% | -0.6 | -0.8% |
| PROSTAMOL | 1 478 700 | -27.2% | 18.4% | -6.3 | 2 068 941 047 | -19.0% | 19.6% | -7.3 | -2.1% |
| RESPERO MYRTOL | 1 187 714 | 80.2% | 8.3% | 3.5 | 563 510 951 | 83.8% | 8.4% | 3.3 | 4.6% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 10 111 960 | -20.9% | 5.0% | -1 | 2 035 267 402 | -7.5% | 4.9% | -0.6 | -4.9% |
| DEXALGIN | 1 645 633 | -11.0% | 0.6% | -0.1 | 704 091 180 | 0.2% | 1.8% | -0.1 | -2.6% |
| ESPUMISAN (ADULTS) | 4 427 873 | -17.0% | 54.1% | -11.9 | 2 258 705 513 | -7.1% | 59.8% | -10.6 | 1.2% |
| ESPUMISAN BABY | 1 448 518 | -15.5% | 37.4% | -4.2 | 910 160 434 | -8.7% | 50.7% | -5.5 | -6.1% |
| FASTUM | 1 064 212 | -25.5% | 1.1% | -0.4 | 553 700 063 | -15.7% | 2.5% | -0.6 | -1.9% |
| IODOMARIN | 3 309 145 | 6.5% | 20.6% | 0.7 | 642 790 721 | 10.1% | 9.2% | 0.1 | 3.0% |
| LIOTON | 1 278 474 | -25.8% | 2.3% | -0.5 | 1 316 347 346 | -7.2% | 4.7% | -0.9 | -8.8% |
| MEZYM | 17 939 607 | -14.5% | 26.1% | -2.9 | 2 729 290 008 | -6.8% | 18.7% | -3 | -5.2% |
| MIG 400 | 8 466 060 | -15.8% | 3.3% | -0.5 | 998 243 738 | -11.9% | 2.5% | -0.6 | -2.6% |
| PROSTAMOL | 1 588 472 | -27.2% | 18.6% | -5.9 | 2 213 255 136 | -19.2% | 19.9% | -6.8 | -4.1% |
| RESPERO MYRTOL | 1 275 325 | 83.8% | 8.3% | 3.7 | 601 783 755 | 86.3% | 8.4% | 3.4 | 3.2% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 225 046 | 22.8% | 3.4% | 0.1 | 52 067 284 | 22.7% | 3.5% | 0.1 | 19.0% |
| DEXALGIN | 18 160 | 7.9% | 0.3% | 0 | 8 556 840 | 1.2% | 1.0% | -0.1 | 13.6% |
| ESPUMISAN (ADULTS) | 56 822 | 1.0% | 41.7% | 0.7 | 32 410 765 | 3.9% | 48.2% | 0.6 | -0.7% |
| ESPUMISAN BABY | 23 738 | -9.5% | 31.6% | -1.7 | 16 611 784 | -8.1% | 46.9% | -1 | -4.6% |
| FASTUM | 14 962 | -5.7% | 0.8% | 0 | 8 384 565 | -8.3% | 2.1% | -0.1 | -1.2% |
| IODOMARIN | 70 586 | 0.8% | 22.5% | 0.1 | 12 994 835 | 0.7% | 9.1% | 0 | 0.2% |
| LIOTON | 13 943 | -19.5% | 1.4% | -0.4 | 15 838 166 | -21.6% | 3.6% | -0.8 | 1.2% |
| MEZYM | 219 530 | 1.5% | 17.7% | -0.3 | 32 581 420 | 2.4% | 12.5% | 0.3 | 2.9% |
| MIG 400 | 144 574 | 7.9% | 2.4% | -0.1 | 17 419 076 | 8.0% | 2.0% | 0 | 13.6% |
| PROSTAMOL | 23 855 | -3.7% | 13.3% | -0.3 | 32 702 984 | -4.5% | 14.0% | -0.2 | -1.5% |
| RESPERO MYRTOL | 37 106 | 18.2% | 7.8% | 0.3 | 18 788 729 | 17.8% | 8.4% | 0.3 | 13.4% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 604 970 | -8.8% | 3.3% | -0.5 | 138 517 736 | -2.4% | 3.4% | -0.4 | 4.9% |
| DEXALGIN | 67 963 | -21.8% | 0.3% | -0.1 | 33 907 140 | -21.4% | 1.1% | -0.3 | -3.7% |
| ESPUMISAN (ADULTS) | 240 711 | 0.5% | 41.3% | -1.5 | 131 026 847 | 4.0% | 48.3% | -0.8 | 4.1% |
| ESPUMISAN BABY | 103 328 | 2.6% | 33.8% | 1.4 | 69 479 607 | 5.8% | 47.4% | 1.6 | -1.6% |
| FASTUM | 72 086 | 12.1% | 0.9% | 0.1 | 40 966 576 | 12.7% | 2.4% | 0.3 | -1.3% |
| IODOMARIN | 299 606 | -16.4% | 23.2% | -1 | 55 472 593 | -16.2% | 9.8% | -0.8 | -12.7% |
| LIOTON | 72 321 | 5.9% | 1.8% | 0.2 | 83 457 879 | 9.9% | 4.3% | 0.5 | -4.0% |
| MEZYM | 921 273 | 0.0% | 18.4% | -0.3 | 136 606 124 | -2.7% | 12.9% | -0.6 | 1.9% |
| MIG 400 | 558 202 | -5.5% | 2.8% | -0.1 | 67 227 770 | -5.7% | 2.2% | -0.1 | -3.7% |
| PROSTAMOL | 101 766 | -2.9% | 14.1% | -1.3 | 140 977 526 | -2.3% | 14.9% | -1.4 | 6.2% |
| RESPERO MYRTOL | 102 019 | 2.1% | 7.0% | -0.6 | 51 471 720 | 5.2% | 7.5% | -0.4 | 11.1% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "BROMHEXINE B-CH"
## [1] "BROMHEXINE B-CH COATED TABLETS 8 MG #25"
## [1] "BROMHEXINE B-CH SOL ORAL 4 MG/5 ML 60 ML #1"
## [1] "ESPUMISAN (ADULTS)"
## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #25"
## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #50"
## [1] "ESPUMISAN (ADULTS) EXTRA GRAN 125 MG #14"
## [1] "ESPUMISAN (ADULTS) L EMULS ORAL 40 MG 30 ML #1"
## [1] "ESPUMISAN BABY"
## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 30 ML #1"
## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 50 ML #1"
## [1] "FASTUM"
## [1] "FASTUM GEL FOR EXT USE 2,5% 100 G #1"
## [1] "FASTUM GEL FOR EXT USE 2,5% 30 G #1"
## [1] "FASTUM GEL FOR EXT USE 2,5% 50 G #1"
## [1] "LIOTON"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 100 G #1"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 30 G #1"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 50 G #1"
## [1] "MEZYM"
## [1] "MEZYM 20000 INTESTINAL-SOLUBLE COATED TABLETS #20"
## [1] "MEZYM FORTE COATED TABLETS #20"
## [1] "MEZYM FORTE COATED TABLETS #80"
## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #20"
## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #50"
## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #20"
## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #50"
## [1] "MEZYM PRO INTESTINAL-SOLUBLE COATED TABLETS #20"
## [1] "DEXALGIN"
## [1] "DEXALGIN 25 COATED TABLETS 25 MG #10"
## [1] "MIG 400"
## [1] "MIG 400 COATED TABLETS 400 MG #10"
## [1] "MIG 400 COATED TABLETS 400 MG #20"
## [1] "PROSTAMOL"
## [1] "PROSTAMOL UNO CAPS 320 MG #30"
## [1] "PROSTAMOL UNO CAPS 320 MG #60"
## [1] "PROSTAMOL UNO CAPS 320 MG #90"
## [1] "IODOMARIN"
## [1] "IODOMARIN 100 TABS 100 MCG #100"
## [1] "IODOMARIN 200 TABS 200 MCG #100"
## [1] "IODOMARIN 200 TABS 200 MCG #50"
## [1] "IODOMARIN FOR THE FUTURE MOTHER TABLETS 140 MG #30"
## [1] "RESPERO MYRTOL"
## [1] "RESPERO MYRTOL CAPS ENTEROSOLUB 120 MG #20"
## [1] "RESPERO MYRTOL FORTE CAPS ENTEROSOLUB 300 MG #20"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs
MI: Fact Digital Costs
MI Estimated Costs: TV costs